Aims: Among patients with acute coronary syndromes (ACS), those with diabetes mellitus (DM) are at particularly high risk of recurrent cardiovascular events and premature death. We aimed to provide a descriptive overview of unadjusted analyses of patient characteristics, ACS management, and outcomes up to 1 year after hospital admission for an ACS/index-ACS event, in patients with DM in contemporary registries in Europe. Methods and results: A total of 10 registries provided data in a systematic manner on ACS patients with DM (total n =28 899), and without DM (total n= 97 505). In the DM population, the proportion of patients with ST-Segment Elevation Myocardial Infarction (STEMI) ranged from 22.1% to 64.6% (other patients had non-ST-Segment Elevation Myocardial Infarction (NSTEMI-ACS) or unstable angina). All-cause mortality in the registries ranged from 1.4% to 9.4% in-hospital; 2.8% to 7.9% at 30 days post-discharge; 5.1% to 10.7% at 180 days post-discharge; and 3.3% to 10.5% at 1 year post-discharge. Major bleeding events were reported in up to 3.8% of patients while in hospital (8 registries); up to 1.3% at 30 days (data from two registries only), and 2.0% at 1 year (one registry only). Registries differed substantially in terms of study setting, site, patient selection, definition and schedule of endpoints, and use of various P2Y12 inhibitors. In most, but not all, registries, event rates in DM patients were higher than in patients without DM. Pooled risk ratios comparing cohorts with DM vs. no DM were in-hospital significantly higher in DM for all-cause death (1.66; 95% CI 1.42-1.94), for cardiovascular death (2.33; 1.78 - 3.03), and for major bleeding (1.35; 1.21-1.52). Conclusion: These registry data from real-life clinical practice confirm a high risk for recurrent events among DM patients with ACS, with great variation across the different registries.

2nd Department of Medicine with Cardiology and Intensive Care Hospital Rudolfstiftung Vienna Austria

AMIS Plus Data Center Epidemiology Biostatistics and Prevention Institute University of Zurich Zurich Switzerland

AMIS Plus Data Center University of Zurich Zurich Switzerland

Cardiac Intensive Care Unit Interventional Cardiology Hospital Cardiologique Centre Hospitalier Régional et Universitaire de Lille Lille France

Cardiocenter 3rd Faculty of Medicine Charles University Prague Czech Republic

Cardiology Department Hospital La Paz Madrid Spain IdiPaz

Cardiology Department University Heart Center University Hospital Zurich University of Zurich Zurich Switzerland

Cardiology Freeman Hospital and Institute of Cellular Medicine Newcastle upon Tyne UK

Cardiology Service Hospital Universitari Vall d'Hebron Barcelona Spain

Cardiology Unit Humanitas Research Hospital Rozzano Italy

Department of Cardiology Clinical Sciences Lund University Skåne University Hospital Lund Sweden

Department of Cardiology Hospital Européen Georges Pompidou and Université Paris Descartes Paris France

Department of Cardiology Leiden University Medical Center Leiden The Netherlands

Department of Cardiology University Hospital Antwerp Edegem Belgium

Department of Cardiovascular Sciences Laboratory of Interventional Cardiology European Hospital Rome Italy

Heart Disease Institute Bellvitge University Hospital Bellvitge Biomedical Research Institute University of Barcelona Barcelona Spain

Institut d'Investigació Sanitària Pere Virgili Cardiology Service Hospital Universitari de Tarragona Joan XXIII Tarragona Spain

Klinikum Ludwigshafen and Institut für Herzinfarktforschung Ludwigshafen Germany

Pôle de L'urgence Service de d'Aide Médicale Urgente du Nord Centre Hospitalier Régional Universitaire de Lille Lille France

Swansea University Medical School Swansea Wales UK

Université Paris 06 ACTION Study Group INSERM UMRS 1166 Institut de Cardiologie Pitié Salpêtrière University Hospital Paris France

University Clinic of Internal Medicine 3 Cardiology and Angiology Medical University of Innsbruck Innsbruck Austria

000      

00000naa a2200000 a 4500

001      

bmc19001290

003      

CZ-PrNML

005      

20190118112234.0

007      

ta

008      

190107s2017 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1093/ehjcvp/pvw049 $2 doi

035    __

$a (PubMed)28329196

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Lettino, Maddalena $u Cardiology Unit, Humanitas Research Hospital, Rozzano (Milano), Italy.

245    10

$a Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes / $c M. Lettino, P. Andell, U. Zeymer, P. Widimsky, N. Danchin, A. Bardaji, JA. Barrabes, A. Cequier, MJ. Claeys, L. De Luca, J. Dörler, D. Erlinge, P. Erne, P. Goldstein, SM. Koul, G. Lemesle, TF. Lüscher, CM. Matter, G. Montalescot, D. Radovanovic, JL. Sendón, P. Tousek, F. Weidinger, CFM. Weston, A. Zaman, J. Li, JW. Jukema, . ,

520    9_

$a Aims: Among patients with acute coronary syndromes (ACS), those with diabetes mellitus (DM) are at particularly high risk of recurrent cardiovascular events and premature death. We aimed to provide a descriptive overview of unadjusted analyses of patient characteristics, ACS management, and outcomes up to 1 year after hospital admission for an ACS/index-ACS event, in patients with DM in contemporary registries in Europe. Methods and results: A total of 10 registries provided data in a systematic manner on ACS patients with DM (total n =28 899), and without DM (total n= 97 505). In the DM population, the proportion of patients with ST-Segment Elevation Myocardial Infarction (STEMI) ranged from 22.1% to 64.6% (other patients had non-ST-Segment Elevation Myocardial Infarction (NSTEMI-ACS) or unstable angina). All-cause mortality in the registries ranged from 1.4% to 9.4% in-hospital; 2.8% to 7.9% at 30 days post-discharge; 5.1% to 10.7% at 180 days post-discharge; and 3.3% to 10.5% at 1 year post-discharge. Major bleeding events were reported in up to 3.8% of patients while in hospital (8 registries); up to 1.3% at 30 days (data from two registries only), and 2.0% at 1 year (one registry only). Registries differed substantially in terms of study setting, site, patient selection, definition and schedule of endpoints, and use of various P2Y12 inhibitors. In most, but not all, registries, event rates in DM patients were higher than in patients without DM. Pooled risk ratios comparing cohorts with DM vs. no DM were in-hospital significantly higher in DM for all-cause death (1.66; 95% CI 1.42-1.94), for cardiovascular death (2.33; 1.78 - 3.03), and for major bleeding (1.35; 1.21-1.52). Conclusion: These registry data from real-life clinical practice confirm a high risk for recurrent events among DM patients with ACS, with great variation across the different registries.

650    _2

$a akutní koronární syndrom $x diagnóza $x mortalita $x terapie $7 D054058

650    _2

$a senioři $7 D000368

650    _2

$a nestabilní angina pectoris $x diagnóza $x mortalita $x terapie $7 D000789

650    12

$a koronární bypass $x škodlivé účinky $x mortalita $7 D001026

650    _2

$a diabetes mellitus 1. typu $x diagnóza $x epidemiologie $x mortalita $x terapie $7 D003922

650    _2

$a diabetes mellitus 2. typu $x diagnóza $x epidemiologie $x mortalita $x terapie $7 D003924

650    _2

$a Evropa $x epidemiologie $7 D005060

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a krvácení $x chemicky indukované $7 D006470

650    _2

$a mortalita v nemocnicích $7 D017052

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a infarkt myokardu bez ST elevací $x diagnóza $x mortalita $x terapie $7 D000072658

650    12

$a koronární angioplastika $x škodlivé účinky $x mortalita $7 D062645

650    _2

$a inhibitory agregace trombocytů $x škodlivé účinky $x terapeutické užití $7 D010975

650    _2

$a lékařská praxe - způsoby provádění $7 D010818

650    _2

$a prognóza $7 D011379

650    _2

$a recidiva $7 D012008

650    _2

$a registrace $7 D012042

650    _2

$a hodnocení rizik $7 D018570

650    _2

$a rizikové faktory $7 D012307

650    _2

$a infarkt myokardu s elevacemi ST úseků $x diagnóza $x mortalita $x terapie $7 D000072657

650    _2

$a časové faktory $7 D013997

655    _2

$a časopisecké články $7 D016428

655    _2

$a multicentrická studie $7 D016448

655    _2

$a pozorovací studie $7 D064888

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Andell, Pontus $u Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

700    1_

$a Zeymer, Uwe $u Klinikum Ludwigshafen and Institut für Herzinfarktforschung, Ludwigshafen, Germany.

700    1_

$a Widimsky, Petr $u Cardiocenter, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

700    1_

$a Danchin, Nicolas $u Department of Cardiology, Hospital Européen Georges Pompidou and Université Paris Descartes, Paris, France.

700    1_

$a Bardaji, Alfredo $u Institut d'Investigació Sanitària Pere Virgili, Cardiology Service, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.

700    1_

$a Barrabes, Jose A $u Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

700    1_

$a Cequier, Angel $u Heart Disease Institute, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Barcelona, Spain.

700    1_

$a Claeys, Marc J $u Department of Cardiology, University Hospital Antwerp, Edegem, Belgium.

700    1_

$a De Luca, Leonardo $u Department of Cardiovascular Sciences, Laboratory of Interventional Cardiology, European Hospital, Rome, Italy.

700    1_

$a Dörler, Jakob $u University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

700    1_

$a Erlinge, David $u Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

700    1_

$a Erne, Paul $u AMIS-Plus Data Center, University of Zurich, Zurich, Switzerland.

700    1_

$a Goldstein, Patrick $u Pôle de L'urgence, Service de d'Aide Médicale Urgente du Nord, Centre Hospitalier Régional, Universitaire de Lille, Lille, France.

700    1_

$a Koul, Sasha M $u Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

700    1_

$a Lemesle, Gilles $u Cardiac Intensive Care Unit, Interventional Cardiology Hospital Cardiologique, Centre Hospitalier Régional et Universitaire de Lille, Lille, France.

700    1_

$a Lüscher, Thomas F $u Cardiology Department, University Heart Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

700    1_

$a Matter, Christian M $u Cardiology Department, University Heart Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

700    1_

$a Montalescot, Gilles $u Université Paris 06, ACTION Study Group, INSERM-UMRS 1166, Institut de Cardiologie, Pitié-Salpêtrière University Hospital (AP-HP), Paris, France.

700    1_

$a Radovanovic, Dragana $u AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

700    1_

$a Sendón, Jose Lopez $u Cardiology Department, Hospital La Paz, Madrid, Spain, IdiPaz.

700    1_

$a Tousek, Petr $u Cardiocenter, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

700    1_

$a Weidinger, Franz $u 2nd Department of Medicine with Cardiology and Intensive Care, Hospital Rudolfstiftung, Vienna, Austria.

700    1_

$a Weston, Clive F M $u Swansea University, Medical School, Swansea, Wales, UK.

700    1_

$a Zaman, Azfar $u Cardiology, Freeman Hospital and Institute of Cellular Medicine, Newcastle-upon, Tyne, UK.

700    1_

$a Li, Jin $u Cardiology Department, University Heart Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

700    1_

$a Jukema, J Wouter $u Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

700    1_

$a ,

773    0_

$w MED00195025 $t European heart journal. Cardiovascular pharmacotherapy $x 2055-6845 $g Roč. 3, č. 4 (2017), s. 198-213

856    41

$u https://pubmed.ncbi.nlm.nih.gov/28329196 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20190107 $b ABA008

991    __

$a 20190118112449 $b ABA008

999    __

$a ok $b bmc $g 1365176 $s 1039413

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2017 $b 3 $c 4 $d 198-213 $i 2055-6845 $m European heart journal. Cardiovascular pharmacotherapy $n Eur Heart J Cardiovasc Pharmacother $x MED00195025

LZP    __

$a Pubmed-20190107